10 31 25 (Topiramate 25 mg)
Pill imprint 10 31 25 has been identified as Topiramate 25 mg.
Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; vulvodynia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 25 mg
- 5.00 mm
- Prescription only
polyethylene glycol 400
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|16590-0824||Stat RX USA LLC (repackager)|
|43063-0094||PDRX Pharmaceuticals Inc (repackager)|
|68387-0558||Keltman Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about topiramate
- Topiramate extended-release capsules
- Topiramate sprinkle capsules
- Topiramate (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.